As Craig Venter's Celera Genomics caught fire, Millennium looked like a more business-focused venture, with a clearer plan to profit.
Venter, who founded Celera Genomics (nyse: CRA - news - people ), was instrumental in creating Celera's gene sequence.
Celera Genomics (nyse: CRA - news - people ) has several diagnostic tests that could bring revenue in the near future.
Celera genomics began life as the swashbuckling mapper of the human genome, but it never could find the profit treasure buried in that map.
"Milken is probably the single most effective layperson advocate for cancer research, " says former National Cancer Institute director Samuel Broder, now an officer at Celera Genomics.
Gene Payoff Sometime later this year Craig Venter, the grandstanding gene hunter at Celera Genomics, will announce that he has sequenced all 23 pairs of human chromosomes.
As the president, chief executive, and founder of Celera Genomics cra (nyse: cra - news - people), he is a kind of ready-made capitalist hero.
Craig Venter, who heads the private company Celera Genomics, concurred.
CNN: Leaders say discovery must be linked to responsible use
Rival descriptions of the human genome were published by Celera Genomics , a private company, and the Human Genome Project , an international government-backed consortium, in rival scientific publications.
Houston's Compaq is developing the supercomputing technology in collaboration with genetic database company Celera Genomics (nyse: CRA - news - people) and the Department of Energy's Sandia National Labs.
And the genome maps created by the government and Celera Genomics, the biotech Venter headed back in 2000, are averages of several individuals, so they miss the very genetic differences that would cause disease.
He hopes to jump-start the efforts of a coterie of tiny biotech firms developing high-speed gene-scanners, in the same way that his work at Celera Genomics forced the government's Genome Project to accelerate its efforts.
He hopes to stimulate the efforts of a group of tiny biotech companies that are developing high-speed gene-scanners in the same way that his work at Celera Genomics forced the government's Genome Project to accelerate its efforts.
In the five years since Lander and Broad had their first talk, companies that aimed to make money off the genome such as Human Genome Sciences and Celera Genomics have seen their stock prices plummet by more than 80%.
Back then, Celera Genomics (nyse: CRA - news - people ) and the publicly funded Human Genome Project (HGP) had yet to show off their drafts of the human DNA sequence and Celera's market cap was nearly eight times what it is now.
Dr Venter was working out his frustrations after having been fired in 2002 from Celera Genomics, a company he helped set up in 1998 with the specific aim of sequencing the human genome faster and better than the public Human Genome Project was managing at the time.
Now, however, the company is positioning itself to become vitally important to the stampede of companies searching to make the jumble of genetic code listed by Celera Genomics cra (nyse: cra - news - people) and the Human Genome Project into drugs and, eventually, money.
For example, Formela says that if Craig Venter , the founder of Celera Genomics (nasdaq: CRA - news - people), were to walk into his office wanting to start a new company, he might jump at the chance before Venter even explained what he was going to do.
In the five years since Lander and Broad had their first talk, companies that aimed to make money off the genome such as Human Genome Sciences (nasdaq: HGSI - news - people ) and Celera Genomics (nyse: CRA - news - people ) have seen their stock prices plummet by more than 80%.
The collection of ordered human genes uncovered jointly by Celera Genomics cra (nyse: cra - news - people) and the federal government's Human Genome Project has the potential to make drug discovery faster and easier by allowing scientists to more quickly figure out what chemicals inside the body a drug has to stop, boost or replace.
FORBES: Rosetta Inpharmatics Reads Genome As Recipe For Drugs
And all these deals in biology may spell an actual market for supercomputers: If Celera needs one, other genomics companies may decide they need one too.
Many genomics companies such as Celera (nyse: CRA - news - people), Incyte (nasdaq: INCY - news - people) and Affymetrix (nasdaq: AFFX - news - people) make their money by helping larger drugmakers identify genes involved in disease.
应用推荐